Testicular cancer
Testicular cancer is the most common malignancy among men between 14 and 44 years of
age, and its incidence has risen over the past two decades in Western countries. Both …
age, and its incidence has risen over the past two decades in Western countries. Both …
Cancer-associated venous thromboembolism: burden, mechanisms, and management
Venous thromboembolism (VTE) is a significant health problem in the general population
but especially in cancer patients. In this review, we discuss the epidemiology and burden of …
but especially in cancer patients. In this review, we discuss the epidemiology and burden of …
Cancer-associated venous thromboembolic disease, version 2.2021, NCCN clinical practice guidelines in oncology
MB Streiff, B Holmstrom, D Angelini, A Ashrani… - Journal of the National …, 2021 - jnccn.org
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Cancer-Associated
Venous Thromboembolic Disease focus on the prevention, diagnosis, and treatment of …
Venous Thromboembolic Disease focus on the prevention, diagnosis, and treatment of …
Risk of arterial thromboembolism in patients with cancer
Background: The risk of arterial thromboembolism in patients with cancer is incompletely
understood. Objectives: The authors aimed to better define this epidemiological relationship …
understood. Objectives: The authors aimed to better define this epidemiological relationship …
[HTML][HTML] The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis
FI Mulder, M Candeloro, PW Kamphuisen… - …, 2019 - ncbi.nlm.nih.gov
We aimed to evaluate the performance of the Khorana score in predicting venous
thromboembolic events in ambulatory cancer patients. Embase and MEDLINE were …
thromboembolic events in ambulatory cancer patients. Embase and MEDLINE were …
Venous and Arterial Thromboembolism in Patients With Cancer: JACC: CardioOncology State-of-the-Art Review
Venous thromboembolism (VTE), including deep vein thrombosis and pulmonary embolism,
represents a major cause of morbidity and mortality in patients with cancer. Arterial …
represents a major cause of morbidity and mortality in patients with cancer. Arterial …
International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with …
D Farge, H Bounameaux, B Brenner… - The Lancet …, 2016 - thelancet.com
Venous thromboembolism (VTE) is the second leading cause of death in patients with
cancer. These patients are at an increased risk of develo** VTE and are more likely to …
cancer. These patients are at an increased risk of develo** VTE and are more likely to …
Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update
GH Lyman, AA Khorana, NM Kuderer… - Journal of Clinical …, 2013 - ascopubs.org
Purpose To provide recommendations about prophylaxis and treatment of venous
thromboembolism (VTE) in patients with cancer. Prophylaxis in the outpatient, inpatient, and …
thromboembolism (VTE) in patients with cancer. Prophylaxis in the outpatient, inpatient, and …
Cisplatin in the modern era: The backbone of first-line chemotherapy for non-small cell lung cancer
DA Fennell, Y Summers, J Cadranel, T Benepal… - Cancer treatment …, 2016 - Elsevier
The treatment of advanced non-small cell lung cancer (NSCLC) may be changing, but the
cisplatin-based doublet remains the foundation of treatment for the majority of patients with …
cisplatin-based doublet remains the foundation of treatment for the majority of patients with …
The incidence of cancer-associated thrombosis is increasing over time
Cancer-associated thrombosis (CAT) is an important cause of morbidity and mortality for
patients with malignancy and varies by primary cancer type, stage, and therapy. We aimed …
patients with malignancy and varies by primary cancer type, stage, and therapy. We aimed …